Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Nifty Pharma ETF · Direct ✕UTI Nifty Bank ETF · Direct ✕

Growth of ₹10,000

Basics

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
CategoryEquity ETFsEquity ETFs
PlanDirectDirect
Fund houseNippon IndiaUTI
NAV₹29.1863₹66.9307
NAV date20 Nov 202620 Nov 2026
History5.4 years6.2 years
Expense ratio0.2%0.0%
StarsNot ratedNot rated
Growth Score——

Returns

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
1 month+10.82%+16.47%
3 months+7.43%+12.37%
6 months+14.54%+21.13%
YTD+25.40%+8.98%
1 year+25.57%+9.37%
3 years (CAGR)+22.02%+14.73%
5 years (CAGR)+16.60%+11.94%
10 years (CAGR)——
Since launch+14.02%+18.31%

Risk

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
Volatility15.0%19.5%
Downside volatility9.0%12.2%
Sharpe1.040.42
Sortino1.720.67
Calmar1.330.80
Return / risk1.470.76
Deepest fall−20.98%−20.59%
Days to recover13690
Below its high−1.75%+0.00%

Against benchmark

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
Alpha+0.00%+0.04%
Beta1.001.00
R²100.0%100.0%
Up capture100.0%100.1%
Down capture100.0%99.9%
Tracking error0.0%0.0%
Information ratio—2.16
Treynor0.140.07

Consistency

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
Best 1-year+65.21%+85.31%
Middle 1-year+13.46%+12.13%
Worst 1-year−15.30%−6.73%
1-year periods with a loss25.8%7.1%
Middle 3-year+20.51%+12.74%
Positive months61.1%58.3%
Best day+3.64%+5.67%
Worst day−4.03%−7.91%
Worst 5% day−1.62%−1.44%
Positive days54.4%53.0%
NAVs a year248248

SIP of ₹10,000 a month

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
5-year XIRR+20.60%+13.56%
5-year value₹10,11,738₹8,48,646
3-year XIRR+19.58%+14.10%
1-year XIRR+34.31%+24.34%

Holdings overlap i

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
Nippon India Nifty Pharma ETF—0%
UTI Nifty Bank ETF0%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Sectors and company size

Nippon India Nifty Pharma ETFUTI Nifty Bank ETF
Large companies45.3%78.0%
Mid companies47.1%22.0%
Small companies7.6%—
Top 10 holdings78.6%87.9%
Largest sectorPharmaceuticals & Biotechnology 100%Banks 100%

Search Growth